Spectranetics to Participate in Upcoming Investor Conferences


COLORADO SPRINGS, Colo., Aug. 20, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be participating in two upcoming investor conferences.

Spectranetics management is scheduled to participate in the 7th Annual Barrington Research Fall Investment Conference in Chicago on Thursday, September 4, 2014.

Spectranetics management is also scheduled to present at the 2014 Morgan Stanley Global Healthcare Conference in New York City on Wednesday, September 10, 2014 at 11:30 am ET. Interested parties can access the live audio webcast at http://www.spectranetics.com. An archived presentation will be available on the website for 30 days.

About Spectranetics

Spectranetics develops, manufactures, markets and distributes single-use medical devices used in minimally invasive procedures within the cardiovascular system. The Company's products are sold in over 65 countries and are used to treat arterial blockages in the heart and legs and in the removal of pacemaker and defibrillator leads.

Spectranetics recently acquired AngioScore, Inc., a leading developer, manufacturer and marketer of cardiovascular, specialty balloons.

The Company's Vascular Intervention (VI) products include a range of laser catheters for ablation of blockages in arteries above and below the knee as well as the AngioSculpt® scoring balloon used in both peripheral and coronary procedures. The Company also markets support catheters to facilitate crossing of peripheral and coronary arterial blockages, and retrograde access and guidewire retrieval devices used in the treatment of peripheral arterial blockages, including chronic total occlusions. The Company markets aspiration and cardiac laser catheters to treat blockages in the heart.

The Lead Management (LM) product line includes excimer laser sheaths, dilator sheaths, mechanical sheaths and accessories for the removal of pacemaker and defibrillator cardiac leads.

For more information, visit www.spectranetics.com.



            

Contact Data